Home

ale nahlas videl oblečenie tentative mic breakpoints candida auris úplne hrať brázda

AST News Update 2019 Practical Tips 1: AST For Candida Species
AST News Update 2019 Practical Tips 1: AST For Candida Species

How to interpret MICs of antifungal compounds according to the revised  clinical breakpoints v. 10.0 European committee on antimicrobial  susceptibility testing (EUCAST) - ScienceDirect
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - ScienceDirect

Candida auris: MDR Fungus Among Us
Candida auris: MDR Fungus Among Us

Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight  Antifungal Compounds for Candida auris and Associated Tentative  Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy

Rationale_9.gif
Rationale_9.gif

Modulation of key antioxidant enzymes and cell cycle arrest as a possible  antifungal mode of action of cinnamaldehyde based azole derivative -  ScienceDirect
Modulation of key antioxidant enzymes and cell cycle arrest as a possible antifungal mode of action of cinnamaldehyde based azole derivative - ScienceDirect

Antifungal Susceptibility Data for 54 Candida auris Isolates | Download  Table
Antifungal Susceptibility Data for 54 Candida auris Isolates | Download Table

Clinical, microbiological, and genomic characteristics of clade-III Candida  auris colonization and infection in southern California, 2019–2022 |  Infection Control & Hospital Epidemiology | Cambridge Core
Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core

How to interpret MICs of antifungal compounds according to the revised  clinical breakpoints v. 10.0 European committee on antimicrobial  susceptibility testing (EUCAST) - Clinical Microbiology and Infection
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection

Summary of susceptibility testing of Candida auris isolate from the... |  Download Table
Summary of susceptibility testing of Candida auris isolate from the... | Download Table

Candida auris Isolates Resistant to Three Classes of Antifungal Medications  — New York, 2019
Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019

In vivo emergence of high-level resistance during treatment reveals the  first identified mechanism of amphotericin B resistance in Candida auris |  bioRxiv
In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris | bioRxiv

JoF | Free Full-Text | International Multicentre Study of Candida auris  Infections
JoF | Free Full-Text | International Multicentre Study of Candida auris Infections

Clinical, microbiological, and genomic characteristics of clade-III Candida  auris colonization and infection in southern California, 2019–2022 |  Infection Control & Hospital Epidemiology | Cambridge Core
Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core

C. auris strains were collected from Montefiore Medical Center (MMC)... |  Download Scientific Diagram
C. auris strains were collected from Montefiore Medical Center (MMC)... | Download Scientific Diagram

Identification and antifungal drug susceptibility pattern of Candida auris  in India Deshkar S, Patil N, Amberkar S, Lad A, Siddiqui F, Sharan S - J  Global Infect Dis
Identification and antifungal drug susceptibility pattern of Candida auris in India Deshkar S, Patil N, Amberkar S, Lad A, Siddiqui F, Sharan S - J Global Infect Dis

MIC50, MIC90, MIC range and geometric mean of five antifungal agents... |  Download Scientific Diagram
MIC50, MIC90, MIC range and geometric mean of five antifungal agents... | Download Scientific Diagram

Antifungal Resistance Trends of Candida auris Clinical Isolates in New York  and New Jersey from 2016 to 2020 | Antimicrobial Agents and Chemotherapy
Antifungal Resistance Trends of Candida auris Clinical Isolates in New York and New Jersey from 2016 to 2020 | Antimicrobial Agents and Chemotherapy

Frontiers | Silver Nanoantibiotics Display Strong Antifungal Activity  Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both  Planktonic and Biofilm Growing Conditions
Frontiers | Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions

Frontiers | Nine Things Genomics Can Tell Us About Candida auris
Frontiers | Nine Things Genomics Can Tell Us About Candida auris

Summary of susceptibility testing of Candida auris isolate from the... |  Download Table
Summary of susceptibility testing of Candida auris isolate from the... | Download Table

JoF | Free Full-Text | Immunopathogenesis of Emerging Candida auris and  Candida haemulonii Strains
JoF | Free Full-Text | Immunopathogenesis of Emerging Candida auris and Candida haemulonii Strains

Triazole antifungal MIC of C. auris clinical isolates and derivative... |  Download Scientific Diagram
Triazole antifungal MIC of C. auris clinical isolates and derivative... | Download Scientific Diagram

Frontiers | Review on Antifungal Resistance Mechanisms in the Emerging  Pathogen Candida auris
Frontiers | Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris